tirzepatide getting banned FDA moves to remove GLP-1 medications from 503B Bulks List The Impact of New FDA

Glycemic improvements often precede significant weight changes, and individual responses vary based on baseline metabolic status, dosing regimen, and adherence to lifestyle modifications

PlexusDx offers semaglutide and tirzepatide pathways through its Weight Management Protocols with published per-protocol pricing on each product page

The amount of hype to evidence is just so skewed, its crazy, Dr Flynn McGuire, who studied the research, told Stat and Undark in 2025

The FDA has highlighted dysesthesia as a safety signal at the higher dose and is calling for ongoing monitoring and further evaluation

So lets rewind for a second